Anderson, Janaina Nogueira http://orcid.org/0000-0002-6476-9578
Ammous, Zineb
Eroglu, Yasemen
Hernandez, Erick
Heubi, James
Himes, Ryan
Palle, Sirish
Funding for this research was provided by:
Travere Therapeutics, Inc. (Travere Therapeutics, Inc.)
Article History
Received: 17 March 2021
Accepted: 2 July 2021
First Online: 14 September 2021
Declarations
:
: Not applicable.
: Not applicable.
: JN: Consulting for Travere Therapeutics. ZA: Consulting and speaking for Travere Therapeutics (2018–2019); advisory board for BioMarin (2018) and Travere Therapeutics (2017). YE: Consulting for Travere Therapeutics. EH: Consulting for Travere Therapeutics. JH: Equity interest in Asklepion; consulting for Alnylam, FrieslandCampina, Travere Therapeutics, Mirum, and Albireo. RH: Consulting and speaking for Alexion and Travere Therapeutics. SP: Consulting for Travere Therapeutics.